Literature DB >> 22077417

Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system.

Alexander Baraniskin1, Martina Deckert, Gernot Schulte-Altedorneburg, Uwe Schlegel, Roland Schroers.   

Abstract

Lymphomas can arise within the central nervous system (CNS) as primary CNS lymphoma (PCNSL) typically involving the brain and less often the leptomeninges, eyes, and spinal cord. In contrast to PCNSL, secondary CNS lymphoma (SCNSL) is considered to originate as quasi metastasis from systemic lymphoma spreading to the CNS. Both types of CNS lymphomas are predominantly tumours of the diffuse large B-cell type and represent aggressive diseases necessitating a rapid diagnosis. Following neuroimaging based on magnetic resonance imaging, stereotaxy and histopathological diagnosis of CNS lymphoma currently remain obligatory to plan treatment. However, progress in cytopathological, immunophenotypic, and molecular genetic analyses of the cerebrospinal fluid (CSF) has been achieved recently and potentially will facilitate lymphoma diagnosis in the future. This review describes the diagnostic procedures in patients with suspected CNS lymphomas, primarily PCNSL. In addition to a summary of the standard diagnostic work-up, an overview and discussion of current data on different techniques for evaluation of the CSF in CNS lymphoma are given.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22077417     DOI: 10.1111/j.1365-2141.2011.08928.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  32 in total

1.  MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma.

Authors:  Alexander Baraniskin; Jan Kuhnhenn; Uwe Schlegel; Wolf Schmiegel; Stephan Hahn; Roland Schroers
Journal:  J Neurooncol       Date:  2012-06-23       Impact factor: 4.130

Review 2.  [Special hematological diagnostics and therapy options for ocular lymphoma taking CNS involvement into account].

Authors:  A Korfel; U Schlegel; R Schroers
Journal:  Ophthalmologe       Date:  2015-03       Impact factor: 1.059

3.  A Demyelinating Disease; What Lies Beneath?

Authors:  Fatma Rabah; Alaa Elmanzalawy; Dipali Bhuyan; Nagwa El-Banna; Ismail Beshlawi
Journal:  Indian J Pediatr       Date:  2015-07-25       Impact factor: 1.967

4.  Fluorescein sodium-guided biopsy or resection in primary central nervous system lymphomas with contrast-enhancing lesion in MRI.

Authors:  Fu-Hua Lin; Xiang-Heng Zhang; Ji Zhang; Zhen-Qiang He; Hao Duan; Chao Ke; Ke Sai; Xiao-Bing Jiang; Fuad Al-Nahari; Shao-Yan Xi; Yong-Gao Mou
Journal:  J Neurooncol       Date:  2018-08-16       Impact factor: 4.130

5.  A haemorrhagic, contrast-enhancing lesion of the basal ganglia.

Authors:  C Taschner; O Staszewski; M Trippel; S Meckel; M Prinz
Journal:  Clin Neuroradiol       Date:  2012-07-31       Impact factor: 3.649

Review 6.  Non-compressive disorders of the chiasm.

Authors:  Valerie A Purvin; Aki Kawasaki
Journal:  Curr Neurol Neurosci Rep       Date:  2014-07       Impact factor: 5.081

7.  Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome.

Authors:  Monique C Minnema; Eva Kimby; Shirley D'Sa; Luc-Matthieu Fornecker; Stéphanie Poulain; Tom J Snijders; Efstathios Kastritis; Stéphane Kremer; Aikaterini Fitsiori; Laurence Simon; Frédéric Davi; Michael Lunn; Jorge J Castillo; Christopher J Patterson; Magali Le Garff-Tavernier; Myrto Costopoulos; Véronique Leblond; Marie-José Kersten; Meletios A Dimopoulos; Steven P Treon
Journal:  Haematologica       Date:  2016-10-06       Impact factor: 9.941

8.  Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for primary central nervous system lymphoma.

Authors:  Alexander Baraniskin; Elena Zaslavska; Stefanie Nöpel-Dünnebacke; Guido Ahle; Sabine Seidel; Uwe Schlegel; Wolff Schmiegel; Stephan Hahn; Roland Schroers
Journal:  Neuro Oncol       Date:  2015-08-06       Impact factor: 12.300

9.  A case of intraventricular primary central nervous system lymphoma.

Authors:  Kimberly Funaro; Katie C Bailey; Sadie Aguila; Steven J Agosti; Christopher Vaillancourt
Journal:  J Radiol Case Rep       Date:  2014-03-01

10.  Corticosteroid pre-treated primary CNS lymphoma: a detailed analysis of stereotactic biopsy findings and consideration of interobserver variability.

Authors:  Evrim Önder; Ata T Arıkök; Sevgen Önder; Ünsal Han; Mehmet Sorar; Hayri Kertmen; Engin D Yılmaz; Ramazan Fesli; Murat Alper
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.